SGC-CBP30: Selective Bromodomain Inhibitor for Epigenetic...
2026-01-19
SGC-CBP30 empowers researchers to precisely dissect CREBBP/EP300-driven transcriptional programs, especially in the context of super-enhancer hijacking and TGF-β/SMAD3 signaling. Its high selectivity and robust cellular activity make it a cornerstone for advanced epigenetics and cancer biology workflows, with proven value in lung adenocarcinoma models.